Home/Filings/4/0001415889-22-009771
4//SEC Filing

INGRAM ROBERT ALEXANDER 4

Accession 0001415889-22-009771

CIK 0001701541other

Filed

Sep 18, 8:00 PM ET

Accepted

Sep 19, 5:08 PM ET

Size

5.3 KB

Accession

0001415889-22-009771

Insider Transaction Report

Form 4
Period: 2022-09-16
Transactions
  • Award

    Common Stock

    2022-09-16$2.62/sh+6,584$17,25033,479 total
Footnotes (2)
  • [F1]These shares were issued in accordance with the Issuer's Third Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
  • [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on September 15, 2022.

Issuer

Black Diamond Therapeutics, Inc.

CIK 0001701541

Entity typeother

Related Parties

1
  • filerCIK 0001219890

Filing Metadata

Form type
4
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 5:08 PM ET
Size
5.3 KB